372 filings
Page 3 of 19
6-K
b5ys3z9mfnyij
23 Jun 23
Current report (foreign)
4:41pm
6-K
l5l803p
2 Jun 23
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
8:51am
6-K
1yjlprh8q 69x22bxb26
2 Jun 23
Current report (foreign)
8:48am
6-K
v93hwwd2o4ew
26 May 23
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
7:43am
6-K
fu3un8jc9i51
25 May 23
Changes in the Supervisory Board of BioNTech SE and Voting Results from the Annual General Meeting 2023
4:06pm
6-K
d2uh23xh
8 May 23
Current report (foreign)
9:22am
6-K
0r76d bm1ws
8 May 23
Current report (foreign)
6:56am
6-K
fdq5vhur
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
abbqxh8u
13 Apr 23
Invitation to the Annual General Meeting 2023
4:25pm
6-K
1yfr20j9k1h ok
3 Apr 23
Current report (foreign)
8:07am
6-K
854otw7mzf
28 Mar 23
BioNTech Announces New ADS Repurchase Program
6:59am
6-K
pgbbpzk
27 Mar 23
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
6:49am
6-K
c17 xkxljkxnocv9i
20 Mar 23
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications
8:00am
6-K
in3r9dj55rvmi ot
14 Mar 23
Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster
6:12pm
6-K
gl59m6 w1
1 Mar 23
Current report (foreign)
9:01am
6-K
itt fxb6s71xpswh
24 Feb 23
Current report (foreign)
8:58am
SC 13G/A
zhufm5
22 Feb 23
BioNTech SE / Medine GmbH ownership change
12:00am
SC 13G/A
tkjimk92 7sgf6ytlhs
14 Feb 23
BioNTech SE / ATHOS KG ownership change
6:06am
S-8
a2aiiaa6hxb2kw1
13 Feb 23
Registration of securities for employees
5:06pm